LMHS Offering WATCHMAN FLX™ Device for Nonvalvular Atrial Fibrillation

posted on: 11/6/2023 7:01:22 PM

Lima Memorial Health System is proud to offer the WATCHMAN FLX™ device for patients with nonvalvular atrial fibrillation (AF). Individuals with AF have a five times greater risk of stroke than individuals with a normal heart rhythm, and the most common treatment to reduce this stroke risk is providing patients with blood-thinning medications. These medications, while effective, can cause serious bleeding over time and can come with requirements and restrictions. The WATCHMAN FLX™ device offers patients an alternative to the long-term use of blood thinners.

It is estimated that seven million Americans are affected by AF, a condition where the heart’s normal beating in its upper chambers is irregular, and blood is not flowing as well as it should from the upper chambers to the lower chambers of the heart. The WATCHMAN device closes off the left atrial appendage (LAA) to keep dangerous blood clots from forming, entering the bloodstream and potentially leading to a stroke. When the LAA is closed off, the risk of stroke can be reduced, and patients may be able to stop taking blood thinners.

“The WATCHMAN device is built upon the most studied and well-established technology and serves as a safe and effective way to reduce the stroke risk for our patients with nonvalvular AF,” shares Dr. Zane W.M. Dean, Cardiologist and Structural Heart Director at Lima Memorial Heart & Vascular Institute. “With this technology, we are able to help a broader range of patients and offer a potentially life-changing treatment to many in our community.”

More than 200,000 patients worldwide have been implanted with WATCHMAN technology. The device is implanted in a one-time procedure and is a permanent device. The procedure is completed under general anesthesia and takes about an hour, with patients expected to stay in the hospital overnight and discharge the next day. Additionally, the device does not need to be replaced and is not visible outside of the body.

Patients interested in learning more about the WATCHMAN device may call Natalie Lammers, PA-C, Structural Heart Coordinator, at 419-998-4404.